Catalyst Pharmaceutical Partners Inc buy Bank of America Co.
Start price
09.01.25
/
50%
€23.55
Target price
09.01.26
€29.13
Performance (%)
-16.45%
End price
10.01.26
€19.68
Summary
This prediction ended on 10.01.26 with a price of €19.68. The prediction for Catalyst Pharmaceutical Partners Inc disappointed with a performance of -16.45%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 7.685% | 7.685% | -4.456% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at Bank of America Co.. They now have a $30.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Bank_of_America_Co_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.95
07.03.24
07.03.24
€21.15
07.03.25
07.03.25
32.99%
08.03.25
08.03.25
